| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.95T | 2.91T | 2.67T | 2.39T | 2.08T | 1.91T |
| Gross Profit | 337.25B | 327.57B | 294.68B | 269.26B | 257.32B | 242.31B |
| EBITDA | 195.98B | 182.81B | 163.49B | 148.58B | 146.52B | 146.82B |
| Net Income | 134.90B | 125.82B | 115.03B | 111.79B | 103.87B | 98.52B |
Balance Sheet | ||||||
| Total Assets | 3.27T | 3.45T | 3.14T | 2.77T | 2.34T | 2.16T |
| Cash, Cash Equivalents and Short-Term Investments | 316.82B | 366.07B | 366.20B | 297.79B | 285.39B | 320.28B |
| Total Debt | 744.34B | 847.77B | 666.75B | 589.53B | 404.45B | 359.13B |
| Total Liabilities | 2.02T | 2.18T | 1.91T | 1.71T | 1.38T | 1.28T |
| Stockholders Equity | 1.23T | 1.26T | 1.21T | 1.05T | 945.71B | 874.84B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -35.90B | 82.23B | -86.91B | -19.20B | 106.74B |
| Operating Cash Flow | 0.00 | 30.72B | 123.73B | -26.17B | 30.21B | 153.10B |
| Investing Cash Flow | 0.00 | -101.67B | -58.64B | -79.38B | -49.47B | -58.10B |
| Financing Cash Flow | 0.00 | 58.44B | -13.85B | 106.59B | -22.62B | -46.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥335.93B | 11.11 | 16.55% | 4.26% | 9.49% | 64.79% | |
75 Outperform | ¥2.61T | 10.54 | 14.23% | 2.47% | 2.27% | 70.36% | |
75 Outperform | ¥1.83T | 12.97 | 11.22% | 1.48% | 5.14% | 773.86% | |
74 Outperform | ¥281.02B | 9.47 | 7.62% | 3.44% | 7.54% | 115.47% | |
71 Outperform | ¥2.86T | 15.14 | 13.56% | 1.96% | 10.52% | 71.09% | |
67 Neutral | ¥2.60T | 15.64 | 16.64% | 1.83% | 6.60% | 114.38% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |